Vortex

[Vortex @VortexBioSci]

Our Director of R&D, Corinne Renier, is featured in the @IBIJournal, discussing non-invasive tumour profiling with liquid biopsy. 📖 Read the full article 👉 https://t.co/b5SWOccTGX #LiquidBiopsy #Oncology #CancerResearch #MedTech #BiotechUK

[Vortex @VortexBioSci]

Very excited to share that we are working with the @UMBaltimore to advance clinical investigations of Vortex's technology alongside UMB's pioneering Tetherchip research. This research team will gain unprecedented insights into #cancer biology https://t.co/nIRK8U5StW

[Vortex @VortexBioSci]

Welcome to industry veteran Nigel Brooksby who has joined our Board as Non-Executive Chairman. Nigel’s experience speaks for itself, notably he was Chairman & CEO of Sanofi UK. Read more about our growth plans here: https://t.co/YIh3eClQdL #oncology #liquidbiopsy #growth

[Vortex @VortexBioSci]

Vortex recently hosted a webinar in collaboration with @PistoiaAlliance, exploring the role of liquid biopsies in advancing precision medicine, with a specific focus on the significance of Rare Cells in a landscape centred around ctDNA.

Watch the webinar: https://t.co/IeNts70EdX

[The ICR @ICR_London]

We're so pleased that @VortexBioSci is expanding liquid biopsy research at The London Cancer Hub’s Innovation Gateway.

The London Cancer Hub is a partnership led by the ICR and the @SuttonCouncil🤝

Learn more below👇
https://t.co/db5eAYy8AH

[Vortex @VortexBioSci]

Vortex is delighted to announce the completion of a £3.2 million investment round, led by @EMVCapital, to support its next phase of growth.

Learn more ➡️https://t.co/hQsJYnAzRB

[Proactive @proactive_x]

$NSCI NetScientific raises £3.2mln for portfolio company Vortex Biotech https://t.co/yTt16mM85W @NetScientific #NSCI

[NetScientific @NetScientific]

NetScientific is delighted to announce the completion of a £3.2 million investment round in its portfolio company @VortexBioSci, led by its corporate finance and VC arm @EMVCapital.

Learn more➡️https://t.co/OsaUbZp6Iz

[Vortex @VortexBioSci]

Vortex has partnered with a US-based biospecimen CRO, MT Group, to initiate a technical feasibility study using clinical samples.

#biotechnology #biopharma #biosciences #liquidbiopsy

[Vortex @VortexBioSci]

CEO of Vortex Biosciences, Paul Jones, featured in the @GOLD_pharma article exploring the UK’s life science initiatives designed to develop a stronger foothold in the global pharma industry and create world-class treatments for patients.

https://t.co/sDyxvOfreO

[Vortex @VortexBioSci]

Vortex is pleased to announce and extend a warm welcome to recent key hires.

▶️Dennis Hutchison - Chief Commercial Officer and US Lead
▶️Jacqueline Hall - VP, Offering Development
▶️John Matthews - VP, Clinical Operations

[Vortex @VortexBioSci]

Vortex is delighted to announce that it has opened a laboratory at The London Cancer Hub’s Innovation Gateway in support of its next phase of growth. The new laboratory is in addition to Vortex’s existing facility in San Francisco, California.

@ICR_London
@SuttonCouncil

[Vortex @VortexBioSci]

Paul Jones, CEO of Vortex Biosciences, will be attending the @PistoiaAlliance Annual Spring Conference in London next Tuesday, April 18.

Learn more about the event: https://t.co/aArMl1uWKG

[EMV Capital plc @EMVCapital]

We are delighted to announce our portfolio company @VortexBioSci has opened a laboratory at The London Cancer Hub's Innovation Gateway, in support of its next phase of growth.

@ICR_London @SuttonCouncil

https://t.co/m8ZLrfWuWK

[BIOS @bios_community]

“An entrepreneurial culture arises from challenging dogma and the status quo. I lead by example in challenging other approaches and question "why things are done the way they are"...”

Dino Di Carlo (@dinodicarlo)— Prof @UCLA

Shoutout: @VortexBioSci, @Cytovale, @UCLATDG, & more

[Vortex @VortexBioSci]

We are pleased to announce the appointment of Paul Jones as CEO of @VortexBioSci. Paul will lead the company's growth strategy around the core technology of the VTX-1 platform for the collecting of viable CTCs, in the growing oncology liquid biopsy market,

[NetScientific @NetScientific]

NetScientific acquires a strategic 30% stake in Vortex Biotech Holdings, owner of former investee company @VortexBioSci. The acquisition is in line with the Company's strategy of deepening stakes in selected portfolio companies with high return potential. https://t.co/HcJrVsxwMD

[SLAS @SLAS_Org]

Elodie Sollier-Christen accepts 2017 SLAS Innovation Award @VortexBioSci #SLAS2017

[SLAS @SLAS_Org]

Congratulations Elodie Sollier-Christen @VortexBioSci 2017 SLAS Innovation Award winner! #SLAS2017 news!